FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Morgan Stanley analyst Drew Ranieri maintained a Sell rating on Avanos Medical (AVNS – Research Report) today and set a price target of $33.00...
000160649812/312022Q1FALSE00016064982022-01-012022-03-3100016064982022-04-26xbrli:sharesiso4217:USD0001606498202...
0001606498falseApril 28, 202200016064982022-04-282022-04-28UNITED STATESSECURITIES AND EXCHANGE...
Avanos Medical, Inc. Announces First Quarter 2022 Results PR Newswire ALPHARETTA, Ga., May 4, 2022 ALPHARETTA...
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2022 Financial Results PR...
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum PR...
JMP Securities analyst David Turkaly reiterated a Hold rating on Avanos Medical (AVNS – Research Report) today. The company's shares closed last...
0001606498falseFebruary 23, 202200016064982022-02-232022-02-23UNITED STATESSECURITIES AND EXCHANGE...
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results PR Newswire ALPHARETTA, Ga., Feb. 23...
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.